drugset / Trial / NCT01788540

Intralipid for Recurrent Miscarriage

NCT01788540

Phase 4 Completed 300 enrolled Woman's Health University Hospital, Egypt
RandomizedParallel-groupDouble-blindTreatment

Summary

Intralipid infusion can improve the outcome in NK cells positive females with history of recurrent miscarriages undergoing IVF/ICSI cycles.

Timeline

Start
2013-02
Primary completion
2016-08
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Intralipid Other / unclassified 2 ml Intravenous